Benitec Biopharma Inc. (BNTC) Misses Q2 EPS by 9c

Benitec Biopharma Inc. (NASDAQ: BNTC) reported Q2 EPS of ($0.20), $0.09 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Benitec Biopharma Inc. (BNTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c